These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2041830

  • 1. Evolution of beta-lactamase inhibitors.
    Jackson D.
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
    [Abstract] [Full Text] [Related]

  • 2. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 3. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Mar; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

  • 4. Overcoming enzymatic resistance in bacteria: impact on future therapy.
    Labia R, Barthélémy M, Péduzzi J, Morand A, Tiwari K, Kazmierczak A.
    J Int Med Res; 1990 Mar; 18 Suppl 4():48D-57D. PubMed ID: 2282969
    [Abstract] [Full Text] [Related]

  • 5. Evolution of beta-lactamase inhibitors.
    Rolinson GN.
    Surg Gynecol Obstet; 1991 Mar; 172 Suppl():11-6. PubMed ID: 2024221
    [Abstract] [Full Text] [Related]

  • 6. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS, Blázquez J, Baquero F, Shoichet BK.
    J Med Chem; 1998 Nov 05; 41(23):4577-86. PubMed ID: 9804697
    [Abstract] [Full Text] [Related]

  • 7. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC, Barry AL.
    J Reprod Med; 1990 Mar 05; 35(3 Suppl):317-21. PubMed ID: 2319514
    [Abstract] [Full Text] [Related]

  • 8. beta-Lactamase activity in mycobacteria including Mycobacterium avium and suppression of their growth by a beta-lactamase-stable antibiotic.
    Prabhakaran K, Harris EB, Randhawa B, Hastings RC.
    Microbios; 1995 Mar 05; 81(328):177-85. PubMed ID: 7752957
    [Abstract] [Full Text] [Related]

  • 9. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb 05; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 10. [Beta-lactamase inhibitors].
    Nishiya H, Kunii O.
    Nihon Rinsho; 1991 Sep 05; 49(9):2046-51. PubMed ID: 1960873
    [No Abstract] [Full Text] [Related]

  • 11. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct 05; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

  • 12. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM, Distler AM, Bonomo RA.
    Biochemistry; 2007 Oct 09; 46(40):11361-8. PubMed ID: 17848099
    [Abstract] [Full Text] [Related]

  • 13. The activity of a sulphone beta-lactamase inhibitor, YTR 830.
    Moosdeen F, Williams J, Yamabe S.
    Chemioterapia; 1987 Jun 09; 6(2 Suppl):206-7. PubMed ID: 2855613
    [No Abstract] [Full Text] [Related]

  • 14. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Jun 09; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 15. Evolution of beta-lactamase inhibitors.
    Rolinson GN.
    J Reprod Med; 1988 Jun 09; 33(6 Suppl):571-3. PubMed ID: 3294401
    [Abstract] [Full Text] [Related]

  • 16. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL, Fasching CE, Peterson LR.
    J Lab Clin Med; 1995 Feb 09; 125(2):200-11. PubMed ID: 7844469
    [Abstract] [Full Text] [Related]

  • 17. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE.
    J Chemother; 1989 Jul 09; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract] [Full Text] [Related]

  • 18. [Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].
    Wildfeuer A, Räder K.
    Arzneimittelforschung; 1991 Jan 09; 41(1):70-3. PubMed ID: 2049115
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis.
    Martin MA, Liebana J, Castillo AM, Gutierrez J, Piédrola G.
    Microbios; 1991 Jan 09; 67(272-273):195-202. PubMed ID: 1779879
    [Abstract] [Full Text] [Related]

  • 20. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
    Maddux MS.
    Pharmacotherapy; 1991 Jan 09; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.